Total Payments
$190,126
2024 Payments
$4,603
Companies
49
Transactions
451
Medicare Patients
855
Medicare Billing
$74,390
Payment Breakdown by Category
Consulting$87,906 (46.2%)
Research$61,292 (32.2%)
Other$23,829 (12.5%)
Food & Beverage$9,561 (5.0%)
Travel$7,357 (3.9%)
Education$180.28 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $87,906 | 34 | 46.2% |
| Unspecified | $61,292 | 24 | 32.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $18,729 | 6 | 9.9% |
| Food and Beverage | $9,561 | 353 | 5.0% |
| Travel and Lodging | $7,357 | 25 | 3.9% |
| Honoraria | $5,100 | 4 | 2.7% |
| Education | $180.28 | 5 | 0.1% |
Payments by Type
General
$128,833
427 transactions
Research
$61,292
24 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ALK-Abello, Inc | $35,819 | 53 | $0 (2024) |
| Glenmark Pharmaceuticals Inc. | $35,118 | 10 | $0 (2018) |
| GlaxoSmithKline, LLC. | $29,352 | 58 | $0 (2024) |
| AQUESTIVE THERAPEUTICS, INC. | $20,666 | 7 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $15,587 | 17 | $0 (2024) |
| GENZYME CORPORATION | $9,905 | 31 | $0 (2024) |
| SANOFI PASTEUR INC. | $8,594 | 2 | $0 (2019) |
| Covis Pharma B.V. | $8,379 | 8 | $0 (2019) |
| Takeda Pharmaceuticals International, Inc. | $6,773 | 5 | $0 (2018) |
| Regeneron Pharmaceuticals, Inc. | $5,768 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,603 | 45 | ALK-Abello, Inc ($2,800) |
| 2023 | $3,548 | 63 | E.R. Squibb & Sons, L.L.C. ($1,575) |
| 2022 | $29,769 | 69 | AQUESTIVE THERAPEUTICS, INC. ($17,971) |
| 2021 | $7,416 | 55 | ALK-Abello, Inc ($4,889) |
| 2020 | $13,781 | 38 | GlaxoSmithKline, LLC. ($9,603) |
| 2019 | $51,727 | 88 | GlaxoSmithKline, LLC. ($17,935) |
| 2018 | $65,046 | 61 | Glenmark Pharmaceuticals Inc. ($30,604) |
| 2017 | $14,237 | 32 | GENZYME CORPORATION ($9,109) |
All Payment Transactions
451 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/16/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $31.79 | General |
| Category: Oncology / Rare Diseases | ||||||
| 12/12/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $27.55 | General |
| Category: BIOLOGIC | ||||||
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TAKHZYRO (Biological) | Food and Beverage | In-kind items and services | $31.45 | General |
| Category: GENETIC DISEASE | ||||||
| 11/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $112.29 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Pulmonology | ||||||
| 10/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TAKHZYRO (Biological) | Food and Beverage | In-kind items and services | $30.99 | General |
| Category: GENETIC DISEASE | ||||||
| 10/09/2024 | ADMA BioManufacturing LLC | — | Consulting Fee | Cash or cash equivalent | $27.17 | General |
| 09/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TAKHZYRO (Biological) | Food and Beverage | In-kind items and services | $25.42 | General |
| Category: GENETIC DISEASE | ||||||
| 08/28/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Inflammation | ||||||
| 08/21/2024 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $28.82 | General |
| Category: Immunology | ||||||
| 08/15/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Inflammation | ||||||
| 08/06/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: Immunology | ||||||
| 06/27/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Inflammation | ||||||
| 06/17/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $27.80 | General |
| Category: IMMUNOLOGY | ||||||
| 06/12/2024 | TerSera Therapeutics LLC | Quzyttir (Drug) | Food and Beverage | In-kind items and services | $33.36 | General |
| Category: Acute Care | ||||||
| 06/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Immunology | ||||||
| 06/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $139.81 | General |
| Category: Immunology | ||||||
| 05/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $9.62 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/29/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Immunology | ||||||
| 05/15/2024 | PFIZER INC. | CUTAQUIG (Biological) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: IMMUNOLOGY | ||||||
| 05/10/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $19.51 | General |
| Category: Dermatology | ||||||
| 05/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TAKHZYRO (Biological) | Food and Beverage | In-kind items and services | $27.34 | General |
| Category: GENETIC DISEASE | ||||||
| 05/07/2024 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $525.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Phase IIb, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Immunogenicity of the Intramuscular Norovirus GI1-GII4 Bivalent Virus-like Particle Vaccine in Healthy Adults Aged 18 - 49 Years | Takeda Pharmaceuticals U.S.A., Inc. | $5,083 | 1 |
| GSP301-304 | Glenmark Pharmaceuticals Inc. | $4,514 | 4 |
| A Phase 3, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age | ModernaTX, Inc. | $1,560 | 1 |
| A 24 MONTH DOUBLE BLIND RANDOMISED PARALLEL GROUP STUDY TO DETERMINE T | GlaxoSmithKline, LLC. | $46.86 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 231 | 553 | $53,985 | $20,256 |
| 2022 | 6 | 229 | 755 | $56,180 | $20,829 |
| 2021 | 6 | 194 | 553 | $48,610 | $17,606 |
| 2020 | 6 | 201 | 702 | $50,605 | $15,699 |
Total Patients
855
Total Services
2,563
Medicare Billing
$74,390
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 73 | 116 | $20,880 | $9,853 | 47.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 43 | 43 | $13,975 | $4,960 | 35.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 52 | 62 | $8,680 | $3,721 | 42.9% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 13 | 236 | $4,720 | $701.23 | 14.9% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 16 | 62 | $2,480 | $425.85 | 17.2% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 21 | 21 | $2,730 | $416.85 | 15.3% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 13 | 13 | $520.00 | $176.93 | 34.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 66 | 89 | $16,020 | $8,006 | 50.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 54 | 54 | $17,550 | $5,902 | 33.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 58 | 69 | $9,660 | $3,804 | 39.4% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 12 | 163 | $3,260 | $1,735 | 53.2% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 21 | 361 | $7,220 | $999.46 | 13.8% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 18 | 19 | $2,470 | $383.61 | 15.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 51 | 82 | $14,760 | $7,555 | 51.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 60 | 79 | $11,060 | $4,373 | 39.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 30 | 30 | $9,750 | $3,229 | 33.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 18 | 18 | $3,960 | $1,083 | 27.4% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2021 | 19 | 324 | $6,480 | $985.24 | 15.2% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 16 | 20 | $2,600 | $381.31 | 14.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 61 | 96 | $17,280 | $6,321 | 36.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 65 | 80 | $11,200 | $3,777 | 33.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 33 | 33 | $10,725 | $2,725 | 25.4% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2020 | 14 | 196 | $3,920 | $1,692 | 43.2% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2020 | 14 | 283 | $5,660 | $835.89 | 14.8% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2020 | 14 | 14 | $1,820 | $347.13 | 19.1% |
About Dr. David Bernstein, M.D
Dr. David Bernstein, M.D is a Internal Medicine healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2005. The National Provider Identifier (NPI) number assigned to this provider is 1558369843.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Bernstein, M.D has received a total of $190,126 in payments from pharmaceutical and medical device companies, with $4,603 received in 2024. These payments were reported across 451 transactions from 49 companies. The most common payment nature is "Consulting Fee" ($87,906).
As a Medicare-enrolled provider, Bernstein has provided services to 855 Medicare beneficiaries, totaling 2,563 services with total Medicare billing of $74,390. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Clinical & Laboratory Immunology, Allergy & Immunology
- Location Cincinnati, OH
- Active Since 07/11/2005
- Last Updated 10/25/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1558369843
Products in Payments
- Odactra (Drug) $25,295
- NUCALA (Biological) $10,513
- DUPIXENT (Drug) $9,142
- ALVESCO (Drug) $8,618
- NO PRODUCT DISCUSSED (Drug) $8,575
- ANORO (Drug) $7,367
- Sympazan (Drug) $2,675
- Ragwitek (Drug) $2,607
- DUPIXENT (Biological) $1,729
- TRELEGY ELLIPTA (Drug) $1,657
- Humira (Biological) $474.87
- FASENRA (Drug) $392.79
- Haegarda (Biological) $305.83
- Xolair (Biological) $298.23
- ORLADEYO (Drug) $265.58
- TEZSPIRE (Biological) $247.49
- CUVITRU (Biological) $219.11
- Hizentra (Biological) $212.00
- TAKHZYRO (Biological) $209.79
- FASENRA (Biological) $203.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Cincinnati
Jonathan Bernstein, Md, MD
Internal Medicine — Payments: $1.2M
Internal Medicine $1.2M
Nelson Watts, M.d, M.D
Internal Medicine — Payments: $788,194
Internal Medicine $788,194
Robert Baughman, M.d, M.D
Internal Medicine — Payments: $766,919
Internal Medicine $766,919
Mark Andolina, Md, MD
Internal Medicine — Payments: $469,821
Internal Medicine $469,821
Amit Govil, M.d, M.D
Internal Medicine — Payments: $410,360
Internal Medicine $410,360
Vincent Martin, Md, MD
Internal Medicine — Payments: $332,673
Internal Medicine $332,673